Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Soubeyrand

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Vaccine|June 21, 2015
Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion studyIlse De Coster, Xavier Fournie, Céline Faure, et al.
International Journal of Cancer|September 26, 2007
Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH studyJean-Luc Prétet, Anne-Carole Jacquard, Xavier Carcopino, et al.
Emerging Infectious Diseases|July 5, 2008
Pertussis surveillance in private pediatric practices, France, 2002-2006Nicole Guiso, France de La Rocque, Elisabeth Njamkepo, et al.
International Journal of Cancer|September 26, 2007
Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH studyJean-Luc Prétet, Anne-Carole Jacquard, Xavier Carcopino, et al.
Vaccine|April 5, 2018
The public health value of vaccination for seniors in EuropeSusanna Esposito, Elisabetta Franco, Gaetan Gavazzi, et al.
Vaccine|January 17, 2016
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccinesPierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Vaccine|July 28, 2016
Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761]Pierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Human Vaccines & Immunotherapeutics|March 20, 2018
Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccineKarl-Ulrich Petry, Kaatje Bollaerts, Paolo Bonanni, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Vaccine|June 21, 2015
Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion studyIlse De Coster, Xavier Fournie, Céline Faure, et al.
International Journal of Cancer|September 26, 2007
Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH studyJean-Luc Prétet, Anne-Carole Jacquard, Xavier Carcopino, et al.
Emerging Infectious Diseases|July 5, 2008
Pertussis surveillance in private pediatric practices, France, 2002-2006Nicole Guiso, France de La Rocque, Elisabeth Njamkepo, et al.
International Journal of Cancer|September 26, 2007
Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH studyJean-Luc Prétet, Anne-Carole Jacquard, Xavier Carcopino, et al.
Vaccine|April 5, 2018
The public health value of vaccination for seniors in EuropeSusanna Esposito, Elisabetta Franco, Gaetan Gavazzi, et al.
Vaccine|January 17, 2016
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccinesPierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Vaccine|July 28, 2016
Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761]Pierre Van Damme, Paolo Bonanni, F Xavier Bosch, et al.
Human Vaccines & Immunotherapeutics|March 20, 2018
Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccineKarl-Ulrich Petry, Kaatje Bollaerts, Paolo Bonanni, et al.
Pageof 2